Article
You have full text access to this OnlineOpen article
Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications
Article first published online: 20 MAY 2009
DOI: 10.1002/pro.156
Copyright © 2009 The Protein Society
Additional Information
How to Cite
Fleury, M. J. J., Touzé, A., Maurel, M.-C., Moreau, T. and Coursaget, P. (2009), Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications. Protein Science, 18: 1425–1438. doi: 10.1002/pro.156
Publication History
- Issue published online: 23 JUN 2009
- Article first published online: 20 MAY 2009
- Accepted manuscript online: 20 MAY 2009 12:00AM EST
- Manuscript Accepted: 22 APR 2009
- Manuscript Revised: 21 APR 2009
- Manuscript Received: 6 FEB 2009
Funded by
- Ligue Contre le Cancer (Comités départementaux d'Indre et Loire et de l'Indre), Vaincre la Mucoviscidose
- Ministère de l'Enseignement Supérieur et de la Recherche
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , , , , , , , , , , , , , , Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial, The Lancet Oncology, 2012, 13, 1, 100

1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
